These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 25133)

  • 41. Molecular pharmacology of the anthracycline drug 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride (Cl 216,942).
    Bowden GT; Garcia D; Peng YM; Alberts DS
    Cancer Res; 1982 Jul; 42(7):2660-5. PubMed ID: 7083158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DNA damage and its repair in transformable mouse fibroblasts treated with N-methyl-N'-nitro-N-nitrosoguanidine.
    Peterson AR; Bertram JS; Heidelberger C
    Cancer Res; 1974 Jul; 34(7):1592-9. PubMed ID: 4833913
    [No Abstract]   [Full Text] [Related]  

  • 43. DNA chain growth during replication of asynchronous L1210 cells. Alkaline elution of large DNA segments from cells lysed on filters.
    Kohn KW; Friedman CA; Ewig RA; Iqbal ZM
    Biochemistry; 1974 Sep; 13(20):4134-9. PubMed ID: 4472075
    [No Abstract]   [Full Text] [Related]  

  • 44. DNA damage in the intracerebral rat gliosarcoma 9L treated with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Gutin PH; Hilton J; Fein VJ; Allan AE; Rottman A; Walker MD
    Cancer Res; 1977 Oct; 37(10):3761-5. PubMed ID: 908019
    [No Abstract]   [Full Text] [Related]  

  • 45. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM; Rustum YM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
    Meriwether WD; Bachur NR
    Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
    [No Abstract]   [Full Text] [Related]  

  • 47. 3-(Tetraacetyl glucopyranos-2-yl)-1-(2-chloroethyl)-1-nitrosourea, an antitumor agent with modified bone marrow toxicity.
    Schein PS; McMenamin MG; Anderson T
    Cancer Res; 1973 Sep; 33(9):2005-9. PubMed ID: 4353476
    [No Abstract]   [Full Text] [Related]  

  • 48. N-trifluoroacetyladriamycin-14-valerate: additional mouse antitumor and toxicity studies.
    Parker LM; Hirst M; Israel M
    Cancer Treat Rep; 1978 Jan; 62(1):119-27. PubMed ID: 272230
    [No Abstract]   [Full Text] [Related]  

  • 49. Induction of resistance to L1210 leukemia in BALB/c X DBA/2Cr F1 mice, with L1210 cells treated with glutaraldehyde and concanavalin A.
    Kataoka T; Oh-hashi F; Tsukagoshi S; Sakurai Y
    Cancer Res; 1977 Apr; 37(4):964-8. PubMed ID: 403001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions of some nitro-derivatives of substituted 9-aminoacridine with DNA.
    Filipski J; Marczyński B; Sadzińska L; Chalupka G; Chorazy M
    Biochim Biophys Acta; 1977 Sep; 478(1):33-43. PubMed ID: 196646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Macromolecular DNA-damage in murine and human leukemic and lymphoid cells after in vitro exposure to ASTA Z 7557 (INN mafosfamide).
    Osieka R; Pannenbäcker R; Schmidt CG
    Invest New Drugs; 1984; 2(2):161-8. PubMed ID: 6469510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of cannabinoids on L1210 murine leukemia. III. Inhibition of respiration.
    Tucker AN; Friedman MA
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):327-32. PubMed ID: 461956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparative characteristics of the antitumor and immunodepressive activity of carminomycin on the L-1210 experimental model].
    Berezina TA; Uteshev BS
    Antibiotiki; 1979 Oct; 24(10):767-71. PubMed ID: 496420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies on a cell line derived from the L1210 murine leukemia with altered surface properties and decreased capacity for tumor production.
    Kessel D; Bosmann HB
    Cancer Res; 1974 Mar; 34(3):603-8. PubMed ID: 4855835
    [No Abstract]   [Full Text] [Related]  

  • 55. Cytotoxicity and deoxyribonucleic acid damage associated with bromoacetate.
    Stratton CE; Ross WE; Chapman S
    Biochem Pharmacol; 1981 Jun; 30(12):1497-500. PubMed ID: 7271843
    [No Abstract]   [Full Text] [Related]  

  • 56. Biochemical studies of a new antitumor agent, O2,2'-cyclocytidine.
    Ho DH
    Biochem Pharmacol; 1974 Apr; 23(8):1235-44. PubMed ID: 4824772
    [No Abstract]   [Full Text] [Related]  

  • 57. Potential antitumor agents. 26. Anionic congeners of the 9-anilinoacridines.
    Denny WA; Atwell GJ; Cain BF
    J Med Chem; 1978 Jan; 21(1):5-10. PubMed ID: 619148
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential antitumor agents. 19. Multiply substituted 4'-(9-acridinylamino)methanesulfonanilides.
    Cain BF; Atwell G
    J Med Chem; 1976 Sep; 19(9):1124-9. PubMed ID: 978676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetic response of cultured Chinese hamster cells to treatment with 4'-[(9-acridinyl)-amino]methanesulphon-m-anisidide-HCl.
    Tobey RA; Deaven LL; Oka MS
    J Natl Cancer Inst; 1978 May; 60(5):1147-53. PubMed ID: 642031
    [No Abstract]   [Full Text] [Related]  

  • 60. Ellipticine and derivatives induce breakage of L1210 cells DNA in vitro.
    Paoletti C; Lesca C; Cros S; Malvy C; Auclair C
    Biochem Pharmacol; 1979; 28(3):345-50. PubMed ID: 426849
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.